Abstract
ObjectivesTo evaluate the risk of haematological malignancies in patients with psoriatic arthritis (PsA) overall, and in relation to treatment with tumour necrosis factor inhibitors (TNFi).MethodsWe identified that patients with PsA...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have